TCF7L2 and hepatocellular carcinoma: In general Tcf7l2 silencing was associated with a gene expression program consistent with reduced cell invasiveness, diminished capacity for liver injury repair and a mesenchymal to epithelial transition (MET) in hepatoma cells.